全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...

Obesity Status and Colorectal Cancer Screening in the United States

DOI: 10.1155/2013/920270

Full-Text   Cite this paper   Add to My Lib

Abstract:

Background. Findings from previous studies on an association between obesity and colorectal cancer (CRC) screening are inconsistent and very few studies have utilized national level databases in the United States (US). Methods. A cross-sectional study was conducted using data from the 2005 Medicare Current Beneficiary Survey to describe CRC screening rate by obesity status. Results. Of a 15,769 Medicare beneficiaries sample aged 50 years and older reflecting 39 million Medicare beneficiaries in the United States, 25% were classified as obese, consisting of 22.4% “obese” (30 ≤ body mass index (BMI) < 35) and 3.1% “morbidly obese” (BMI ≥ 35) beneficiaries. Almost 38% of the beneficiaries had a body mass index level equivalent to overweight (25 ≤ BMI < 30). Of the study population, 65.3% reported having CRC screening (fecal occult blood testing or colonoscopy). Medicare beneficiaries classified as “obese” had greater odds of CRC screening compared to “nonobese” beneficiaries after controlling for other covariates ( = 1.25; 95% CI: 1.12–1.39). Conclusions. Findings indicate that obesity was not a barrier but rather an assisting factor to CRC screening among Medicare beneficiaries. Future studies are needed to evaluate physicians’ ordering of screening tests compared to screening claims among Medicare beneficiaries to better understand patterns of patients’ and doctors’ adherence to national CRC screening guidelines. 1. Introduction According to the American Cancer Society, colorectal cancer (CRC) is the third most common cancer diagnosed and the third leading cause of cancer-related mortality in both men and women in the United States (US) [1]. While these statistics are alarming, the death rate from CRC has decreased for more than 20 years due to early detection of removable polyps by colorectal screening tests [2]. According to the US Preventive Services Task Force (USPSTF), routine screening may reduce the number of people who die of colorectal cancer [3]. Additionally, treatment for CRC has vastly improved over the last several years, and as a result, there are now more than one million survivors of CRC in the US [4]. The risk of developing colorectal cancer in a lifetime is about 1 in 19 and a number of risk factors associated with CRC have been identified [2]. Established risk factors include increased age, personal history of inflammatory bowel disease, colorectal polyps, and family history of colorectal cancer [5]. In addition, certain behavioral factors such as smoking, heavy alcohol use, and obesity, have shown to be the strongest links to an

References

[1]  American Cancer Society, “Key Statistics on Colorectal Cancer,” 2011, http://www.cancer.org/Cancer/ColonandRectumCancer/ DetailedGuide/colorectal-cancer-key-statistics.
[2]  L. A. G. Ries, D. Melbert, M. Krapcho et al., Eds., SEER Cancer Statistics Review, 1975–2005, National Cancer Institute, Bethesda, Md, USA, 2008, http://seer.cancer.gov/csr/1975_2005/.
[3]  US Preventive Services Task Force, “Screening for colorectal cancer: recommendation and rationale,” Annals of Internal Medicine, vol. 137, pp. 129–131, 2002.
[4]  American Cancer Society, “What are the survival rates for colorectal cancer by stage?” 2011, http://www.cancer.org/Cancer/ColonandRectumCancer/DetailedGuide/colorectal-cancer-survival-rates.
[5]  American Cancer Society, “Factors for Colorectal Cancer,” 2011, http://www.cancer.org/Cancer/ColonandRectumCancer/DetailedGuide/colorectal-cancer-risk-factors.
[6]  A. E. Field, E. H. Coakley, A. Must et al., “Impact of overweight on the risk of developing common chronic diseases during a 10-year period,” Archives of Internal Medicine, vol. 161, no. 13, pp. 1581–1586, 2001.
[7]  M. Heo, D. B. Allison, and K. R. Fontaine, “Overweight, obesity, and colorectal cancer screening: disparity between men and women,” BMC Public Health, vol. 4, article 53, 2004.
[8]  A. B. Rosen and E. C. Schneider, “Colorectal cancer screening disparities related to obesity and gender,” Journal of General Internal Medicine, vol. 19, no. 4, pp. 332–338, 2004.
[9]  J. M. Ferrante, P. Ohman-Strickland, S. V. Hudson, K. A. Hahn, J. G. Scott, and B. F. Crabtree, “Colorectal cancer screening among obese versus non-obese patients in primary care practices,” Cancer Detection and Prevention, vol. 30, no. 5, pp. 459–465, 2006.
[10]  C. C. Wee, R. S. Phillips, and E. P. McCarthy, “BMI and cervical cancer screening among white, African-American, and hispanic women in the United States,” Obesity Research, vol. 13, no. 7, pp. 1275–1280, 2005.
[11]  V. W. Chang, D. A. Asch, and R. M. Werner, “Quality of care among obese patients,” Journal of the American Medical Association, vol. 303, no. 13, pp. 1274–1281, 2010.
[12]  Center for Medicare & Medicaid Services, “Medicare Current Beneficiary Survey Overview,” 2011, http://www.cms.gov/Research-Statistics-Data-and-Systems/Research/MCBS/index.html?redirect=/MCBS.
[13]  Research Data Assistance Center, “MCBS Frequently Asked Questions,” 2011, http://www.cms.gov/Research-Statistics-Data-and-Systems/Research/ResearchGenInfo/ResearchDataAssistanceCenter.html.
[14]  A. Lo, A. Chu, and R. Apodaca, Redesign of the Medicare Current Beneficiary Survey Sample, Westat, Inc., Rockville, Md, USA, 2003, http://www.amstat.org/sections/srms/Proceedings/y2002/Files/JSM2002-000662.pdf.
[15]  World Health Organization, Obesity: Preventing And Managing the Global Epidemic: Report of a WHO Consultation on Obesity, WHO, Geneva, Switzerland, 2000, http://www.who.int/nutrition/publications/obesity/WHO_TRS_894/en/index.html.
[16]  Center for Disease Control and Prevention, “Overweight and obesity,” 2011, http://www.cdc.gov/obesity/index.html.
[17]  C. W. Wee, E. P. McCarthy, R. B. Davis, and R. S. Phillips, “Screening for cervical and breast cancer: is obesity an unrecognized barrier to preventive care?” Annals of Internal Medicine, vol. 132, no. 9, pp. 697–704, 2000.
[18]  C. D. Scales Jr., L. H. Curtis, R. D. Norris, K. A. Schulman, P. Dahm, and J. W. Moul, “Relationship between body mass index and prostate cancer screening in the United States,” Journal of Urology, vol. 177, no. 2, pp. 493–498, 2007.
[19]  Centers for Medicare & Medicaid Services, “Medicare Eligibility. U.S. Department of Health and Human Services,” 2008, http://www.medicare.gov/MedicareEligibility/Home.asp?dest=NAV|Home|GeneralEnrollment#TabTop.
[20]  National Task Force on the Prevention and Treatment of Obesity, “Medical care for obese patients: advice for health care professionals,” American Family Physician, vol. 65, pp. 81–88, 2002.

Full-Text

comments powered by Disqus

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133